middle.news
Miro Sciences advances StemSmart towards Crohn’s trial after TGA inspection
9:03am on Thursday 12th of November, 2026 AEDT
•
Biotechnology
Read Story
Miro Sciences advances StemSmart towards Crohn’s trial after TGA inspection
9:03am on Thursday 12th of November, 2026 AEDT
Key Points
TGA inspection completed at Q-Gen Cell Therapeutics in Brisbane
StemSmart manufacturing transfer is progressing ahead of a planned Phase 2 trial
Trial initiation is targeted by the end of calendar 2026, subject to approvals
Recent FDA feedback and Southern Star Research appointment add to development activity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Miro Sciences (ASX:MSX)
OPEN ARTICLE